[Antihypertensive agents].
D000086:Acetazolamide / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D008725:Bis-Trimethylammonium Compounds / Q000627:therapeutic use; D001949:Bretylium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D002714:Chlorisondamine / Q000627:therapeutic use; D002752:Chlorthalidone / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006584:Hexamethonium Compounds / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007022:Hypotension / Q000139:chemically induced; D008464:Mecamylamine / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D010146:Pain; D010306:Parotid Gland; D010393:Pempidine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000627:therapeutic use
D000959:Antihypertensive Agents; D008725:Bis-Trimethylammonium Compounds; D001949:Bretylium Compounds; D004232:Diuretics; D006146:Guanidines; D006584:Hexamethonium Compounds; D013449:Sulfonamides; D006852:Hydrochlorothiazide; D006830:Hydralazine; D008750:Methyldopa; D008464:Mecamylamine; D005665:Furosemide; D002714:Chlorisondamine; D010393:Pempidine; D000086:Acetazolamide; D002752:Chlorthalidone; D010646:Phentolamine; D006145:Guanethidine
Blutdrucksenkende Pharmaka.